These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 16729326)

  • 21. Prognostic indicators of quality of life after cholecystectomy for biliary dyskinesia.
    Geiger TM; Awad ZT; Burgard M; Singh A; Davis W; Thaler K; Miedema BW
    Am Surg; 2008 May; 74(5):400-4. PubMed ID: 18481495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ursodeoxycholic acid on splanchnic and systemic hemodynamics. A double-blind, cross-over, placebo-controlled study in healthy volunteers.
    Schiedermaier P; Hansen S; Asdonk D; Brensing K; Sauerbruch T
    Digestion; 2000; 61(2):107-12. PubMed ID: 10705174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones.
    Della Penna A; Lange J; Hilbert J; Archid R; Königsrainer A; Quante M
    Obes Surg; 2019 Apr; 29(4):1216-1221. PubMed ID: 30604076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gallbladder management during laparoscopic Roux-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatment are not necessary.
    Patel KR; White SC; Tejirian T; Han SH; Russell D; Vira D; Liao L; Patel KB; Gracia C; Haigh P; Dutson E; Mehran A
    Am Surg; 2006 Oct; 72(10):857-61. PubMed ID: 17058721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective, double-blinded, randomized, placebo-controlled comparison of local anesthetic and nonsteroidal anti-inflammatory drugs for postoperative pain management after laparoscopic surgery.
    Newcomb W; Lincourt A; Hope W; Schmelzer T; Sing R; Kercher K; Heniford BT
    Am Surg; 2007 Jun; 73(6):618-24; discussion 624-5. PubMed ID: 17658101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nifedipine is not feasible for biliary pain in patients with gallbladder stones.
    Sand JA; Frey T; Malminiemi K; Nordback IH
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):608-12. PubMed ID: 10599953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trait anxiety predicts unsuccessful surgery in gallstone disease.
    Mertens MC; Roukema JA; Scholtes VP; De Vries J
    Psychosom Med; 2010 Feb; 72(2):198-205. PubMed ID: 20064903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group.
    Gastroenterology; 1980 Mar; 78(3):542-8. PubMed ID: 6985882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of prolonged wait before gallbladder surgery.
    Cheruvu CV; Eyre-Brook IA
    Ann R Coll Surg Engl; 2002 Jan; 84(1):20-2. PubMed ID: 11892728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Symptomatic gallstone disease: an indication for surgery].
    Schiphorst AH; Besselink MG; Venneman NG; Go PM
    Ned Tijdschr Geneeskd; 2006 Nov; 150(44):2405-9. PubMed ID: 17131696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of gallbladder motility to viscosity and composition of gallbladder bile in patients with cholesterol gallstones.
    Gründel D; Jüngst C; Straub G; Althaus R; Schneider B; Spelsberg FW; Hüttl TP; del Pozo R; Jüngst D; Neubrand M
    Digestion; 2009; 79(4):229-34. PubMed ID: 19390195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propinox in biliary colic: a multicenter, randomized, prospective and parallel double-blind study of three doses of propinox versus placebo in acute biliary colic pain.
    de los Santos AR; Martí ML; Di Girolamo G; Diego Espinosa J; Morano MA; Tobar JC; Del Prete C
    Int J Tissue React; 1999; 21(1):13-8. PubMed ID: 10463136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gallstones - approach to medical management.
    Konikoff FM
    MedGenMed; 2003 Oct; 5(4):8. PubMed ID: 14745355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial.
    Udelson JE; Orlandi C; Ouyang J; Krasa H; Zimmer CA; Frivold G; Haught WH; Meymandi S; Macarie C; Raef D; Wedge P; Konstam MA; Gheorghiade M
    J Am Coll Cardiol; 2008 Nov; 52(19):1540-5. PubMed ID: 19007589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What symptoms does cholecystectomy cure? Insights from an outcomes measurement project and review of the literature.
    Fenster LF; Lonborg R; Thirlby RC; Traverso LW
    Am J Surg; 1995 May; 169(5):533-8. PubMed ID: 7747835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Routine cholecystectomy during laparoscopic biliopancreatic diversion with duodenal switch is not necessary.
    Bardaro SJ; Gagner M; Consten E; Inabnet WB; Herron D; Dakin G; Pomp A
    Surg Obes Relat Dis; 2007; 3(5):549-53. PubMed ID: 17903779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?
    Swartz DE; Felix EL
    Surg Obes Relat Dis; 2005; 1(6):555-60. PubMed ID: 16925290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial.
    Färkkilä M; Karvonen AL; Nurmi H; Nuutinen H; Taavitsainen M; Pikkarainen P; Kärkkäinen P
    Hepatology; 2004 Dec; 40(6):1379-86. PubMed ID: 15565569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial.
    Papatheodoridis GV; Hadziyannis ES; Deutsch M; Hadziyannis SJ
    Am J Gastroenterol; 2002 Aug; 97(8):2063-70. PubMed ID: 12190178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome.
    Nitti VW; Dmochowski R; Sand PK; Forst HT; Haag-Molkenteller C; Massow U; Wang J; Brodsky M; Bavendam T
    J Urol; 2007 Dec; 178(6):2488-94. PubMed ID: 17937959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.